We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Bernard Zinman

Bernard Zinman CM, MD, FRCPC, FACP

Director, Leadership Sinai Centre for Diabetes; Sam and Judy Pencer Family Chair in Diabetes Research, Mount Sinai Hospital and the University of Toronto; Professor of Medicine, University of Toronto, Canada

Biographical Sketch:

Bernard Zinman is director of the Leadership Sinai Centre for Diabetes and holds the Sam and Judy Pencer Family Chair in Diabetes Research at Mount Sinai Hospital and the University of Toronto, Canada. He is professor of medicine at the University of Toronto and senior scientist at the Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto. Dr Zinman completed his medical degree at McGill University in Montreal, Quebec, and received further training in endocrinology at the University of Toronto.

His main research interests include the long-term complications of diabetes, the development of new therapies for type 1 and type 2 diabetes, diabetes in aboriginal communities, and studies directed at the prevention of diabetes. He is the recipient of numerous awards and has authored more than 400 publications in national and international journals and over 60 book chapters and editorials. Notably, Dr Zinman was appointed to the Order of Canada, in recognition of his achievements in diabetes patient care and research.

Positions:

Director, Leadership Sinai Centre for Diabetes; Sam and Judy Pencer Family Chair in Diabetes Research, Mount Sinai Hospital and University of Toronto; Professor of Medicine, University of Toronto; Senior Scientist, Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, Canada.

Degrees:

MD: McGill University, Montreal, Quebec

Postgraduate Training: Endocrinology, University of Toronto

Clinical Interests:

Long-term complications of diabetes; development of new therapies for type 1 and type 2 diabetes; diabetes in aboriginal communities; diabetes prevention

Disclosures

1. Serve(d) as Consultant or Advisor with: Novo Nordisk, Boehringer Ingelheim, Eli Lilly, Astra Zeneca, BMS, Janssen, Takeda, and Sanofi Aventis

2. Receive(d) Institutional Grant Money from: Novo Nordisk, Boehringer Ingelheim, and Merck